Puma Biotechnology Inc
NASDAQ:PBYI

Watchlist Manager
Puma Biotechnology Inc Logo
Puma Biotechnology Inc
NASDAQ:PBYI
Watchlist
Price: 3.045 USD 2.53%
Market Cap: 149.4m USD
Have any thoughts about
Puma Biotechnology Inc?
Write Note

Relative Value

The Relative Value of one PBYI stock under the Base Case scenario is 6.976 USD. Compared to the current market price of 3.045 USD, Puma Biotechnology Inc is Undervalued by 56%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PBYI Relative Value
Base Case
6.976 USD
Undervaluation 56%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
68
vs Industry
88
Median 3Y
0.7
Median 5Y
0.9
Industry
8.1
Forward
0.6
vs History
14
vs Industry
10
Median 3Y
10.4
Median 5Y
-3.8
Industry
23
Forward
11.2
vs History
69
vs Industry
14
Median 3Y
5.2
Median 5Y
6.7
Industry
23.4
vs History
25
vs Industry
10
Median 3Y
-2.8
Median 5Y
-4.1
Industry
27.3
vs History
74
vs Industry
27
Median 3Y
4.7
Median 5Y
5.5
Industry
2.6
vs History
93
vs Industry
80
Median 3Y
0.7
Median 5Y
0.9
Industry
8.1
Forward
0.4
vs History
92
vs Industry
76
Median 3Y
1
Median 5Y
1.2
Industry
9.6
vs History
47
vs Industry
13
Median 3Y
4.3
Median 5Y
3
Industry
4.3
Forward
2.8
vs History
47
vs Industry
10
Median 3Y
6.1
Median 5Y
4.8
Industry
3.8
Forward
4
vs History
69
vs Industry
14
Median 3Y
4.8
Median 5Y
6.5
Industry
6
vs History
55
vs Industry
11
Median 3Y
3.2
Median 5Y
5.3
Industry
3.8
vs History
88
vs Industry
55
Median 3Y
1.3
Median 5Y
1.6
Industry
4.8

Multiples Across Competitors

PBYI Competitors Multiples
Puma Biotechnology Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Puma Biotechnology Inc
NASDAQ:PBYI
145.6m USD 0.7 16.9 3 4.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
300.2B USD 5.4 59 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.4 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD 11.9 -263.9 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD 4.1 910.1 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.7 20.8 25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD 6.3 18.8 17.3 19.2
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
US
Puma Biotechnology Inc
NASDAQ:PBYI
Average P/E: 179.3
16.9
-52%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.1
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.7
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
US
Puma Biotechnology Inc
NASDAQ:PBYI
Average EV/EBITDA: 15.7
3
-66%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.8
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
US
Puma Biotechnology Inc
NASDAQ:PBYI
Average EV/EBIT: 20.6
4.9
-56%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
25.9
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top